Bdsure 22.5 mg Injection injection is a Synthetically prepared Nonapeptide having Potent gonadotropin-releasing hormone receptor (GnRHR) agonist activity. Generally, it is used different Clinical Conditions, including Uterine Fibroids, Prostate cancer, Endometriosis, and in vitro fertilization techniques. Bdsure 22.5 mg Injection has proven efficacy in the treatment of Central Precocious Puberty in children.
Bdsure 22.5 mg Injection injection is available as depot suspension, which gets deposited in fatty tissues for a longer period leads to sustained action. Bdsure 22.5 mg Injection is given IM or Subcutaneously, so less painful compared to the other administration route.
Bdsure 22.5 mg Injection injection comes as a Long acting Suspension, administered by the Intramuscular or Subcutaneous route in Fatty tissue of the body, generally given around the Navel by skipping 2 inches on either side of the Navel or at the Upper thigh part where tissues are soft. The recommended dose is 1mg given as Songle daily Subcutaneous injection. But the dosage may vary with the Age, sex and Disease condition. So Bdsure 22.5 mg Injection is advisable to follow the instructions of your Health Care professional. Store it at Room temperature (25°C), do not freeze and keep it away from direct sun light and Children.
Bdsure 22.5 mg Injection is an agonist of Gonadotropin-releasing hormone receptor, which leads to suppression of Gonadotrope secretion of Luteinizing Hormone and Follicle stimulating hormone. Initially, it increases the level of Estrogen and Testosterone irrespective of sex. But a continuation of this therapy decreases the level of Testosterone in males and estrogen in females.